基于CT的深度学习影像组学列线图在透明细胞肾细胞癌结局预测中优于现有预后模型:一项多中心研究
本研究纳入799例局限性及45例转移性透明细胞肾细胞癌患者,开发并验证基于CT的深度学习影像组学列线图(DLRN)预测无复发生存和总生存,并与SSIGN、UISS、MSKCC和IMDC模型比较。在测试队列中,DLRN预测局限性ccRCC无复发生存的1、3、5年时间AUC分别为0.921、0.911、0.900,C-index为0.883,优于SSIGN和UISS;预测转移性ccRCC总生存的1、3、5年时间AUC分别为0.594、0.649、0.754,高于MSKCC和IMDC。
要点
- DLRN预测局限性ccRCC无复发生存的测试队列1、3、5年时间AUC分别为0.921、0.911、0.900。
- DLRN预测转移性ccRCC总生存的测试队列1、3、5年时间AUC分别为0.594、0.649、0.754。
- DLRN在预测局限性ccRCC无复发生存时净获益优于SSIGN和UISS。
核心结论
- DLRN能准确预测ccRCC患者结局,并优于现有预后模型。
研究设计与样本
- 多中心研究,纳入799例局限性(训练/测试队列558/241)和45例转移性ccRCC患者,开发DLRN预测局限性患者无复发生存及转移性患者总生存,并与SSIGN、UISS、MSKCC、IMDC比较,采用Kaplan-Meier曲线、时间依赖AUC、Harrell C-index和决策曲线分析评估。
诊断标准与关键数值
- 测试队列中,DLRN预测局限性ccRCC无复发生存的1、3、5年时间AUC分别为0.921、0.911、0.900,C-index为0.883;预测转移性ccRCC总生存的1、3、5年时间AUC分别为0.594、0.649、0.754。
临床应用与阅片要点
- DLRN可能促进ccRCC患者的个体化治疗、监测和辅助试验设计。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To develop and validate a CT-based deep learning radiomics nomogram (DLRN) for outcome prediction in clear cell renal cell carcinoma (ccRCC), and its performance was compared with the Stage, Size, Grade, and Necrosis (SSIGN) score, the University of California, Los Angeles, Integrated Staging System (UISS), the Memorial Sloan-Kettering Cancer Center (MSKCC), and the International Metastatic Renal Cell Database Consortium (IMDC).
METHODS: A multicenter of 799 localized (training/ test cohort, 558/241) and 45 metastatic ccRCC patients were studied. A DLRN was developed for predicting recurrence-free survival (RFS) in localized ccRCC patients, and another DLRN was developed for predicting overall survival (OS) in metastatic ccRCC patients. The performance of the two DLRNs was compared with that of the SSIGN, UISS, MSKCC, and IMDC. Model performance was assessed with Kaplan-Meier curves, time-dependent area under the curve (time-AUC), Harrell's concordance index (C-index), and decision curve analysis (DCA).
RESULTS: In the test cohort, the DLRN achieved higher time-AUCs (0.921, 0.911, and 0.900 for 1, 3, and 5 years, respectively), C-index (0.883), and net benefit than SSIGN and UISS in predicting RFS for localized ccRCC patients. The DLRN provided higher time-AUCs (0.594, 0.649, and 0.754 for 1, 3, and 5 years, respectively) than MSKCC and IMDC in predicting OS for metastatic ccRCC patients.
CONCLUSIONS: The DLRN can accurately predict outcomes and outperformed the existing prognostic models in ccRCC patients.
CLINICAL RELEVANCE STATEMENT: This deep learning radiomics nomogram may facilitate individualized treatment, surveillance, and adjuvant trial design for patients with clear cell renal cell carcinoma.
KEY POINTS: • SSIGN, UISS, MSKCC, and IMDC may be insufficient for outcome prediction in ccRCC patients. • Radiomics and deep learning allow for the characterization of tumor heterogeneity. • The CT-based deep learning radiomics nomogram outperforms the existing prognostic models in ccRCC outcome prediction.
引用
- Nie, Yang, Wang, et al. A CT-based deep learning radiomics nomogram outperforms the existing prognostic models for outcome prediction in clear cell renal cell carcinoma: a multicenter study. Eur Radiol. 2023. PMID: 37389608. doi:10.1007/s00330-023-09869-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。